This is an official version.

Copyright © 2006: Queen’s Printer,
St. John's, Newfoundland and Labrador, Canada

Important Information
(Includes details about the availability of printed and electronic versions of the Statutes.)

Newfoundland and Labrador
Regulation 2002


NEWFOUNDLAND AND LABRADOR REGULATION 41/02

NEWFOUNDLAND AND LABRADOR
REGULATION 41/02

Nurse Practitioner Regulations (Amendment)
under the
Registered Nurses Act

(Filed May 27, 2002)

Under the authority of section 22.1 of the Registered Nurses Act, the council, with the approval of the minister, makes the following regulations.

Dated at St. John’s, May 21, 2002.

Sharon Smith
President of the Council of the
Association of Registered Nurses of
Newfoundland

Gerald Smith
Minister of Health and Community Services

REGULATIONS

Analysis


        1.   Sch. B Amdt.

        2.   Sch. C Amdt.


NLR 65/98
as amended

        1. (1) Schedule B of the Nurse Practitioner Regulations is amended under the heading "BIOCHEMISTRY"

             (a)  by inserting immediately before the word "Potassium" the words "Lipid Profile"; and

             (b)  by inserting immediately before the word "Urea" the words "Thyroid Stimulating Hormone".

             (2)  Schedule B of the Regulations is amended under the heading "FORMS OF ENERGY" .

             (a)  by adding immediately before the provision "EKG" the words "Chest X-Ray"; and

             (b)  by deleting the phrase "X-Rays for trauma (limbs) -following consultation with a physician" and substituting the words "X-ray limb".

 

        2. Schedule C of the regulations is amended

             (a)  under the heading "Anti-infective Drugs" and the sub-heading "Antibiotics" and the further sub-heading "Antifungal Antibiotics", by adding immediately after the words "nystatin (all forms)" the word "terazol";

             (b)  by adding under the heading "Central Nervous System Drugs" and the subheading "Analgesics and Antipyretics" and the provisions following that subheading, the subheading "Antihistamines" and the words "diphenhydramine (oral and injectible)";

             (c)  under the heading "Gastrointestinal Drugs" immediately after the subheading "Antiemetic" by adding before the word "metoclopramide" the words "dimenhydrinate (any route)";

             (d)  under the heading "Hormones and Synthetic Substitutes" by adding immediately after the subheading "Contraceptives" the words "Depo-Provera injectable".